EADV 2025 Paris: The future of dermatology

…and how we are alre­a­dy imple­men­ting them at the Swiss Der­ma Cli­nic today

This year in Paris, the Euro­pean Aca­de­my of Der­ma­to­lo­gy and Vene­reo­lo­gy (EADV) once again demons­tra­ted how rapidly der­ma­to­lo­gy is deve­lo­ping. As a der­ma­to­lo­gist, sur­ge­on, trai­ner and medi­cal direc­tor of the Swiss Der­ma Cli­nic, I was able to take part in this inter­na­tio­nal­ly important con­gress and bring the latest sci­en­ti­fic fin­dings to Zurich for our patients.

Here are a few high­lights from a the­ma­ti­cal­ly rich, diver­se and sci­en­ti­fi­cal­ly impres­si­ve congress:

1 Vision 2035: On the way to curing psoriasis

One of the most impres­si­ve moments was the pre­sen­ta­ti­on by Pro­fes­sor Chris­to­pher Grif­fiths: the so-cal­led „Mars Shot“ – the sci­en­ti­fic visi­on of achie­ving a cure for pso­ria­sis by 2035.

What sounds like sci­ence fic­tion today is actual­ly based on real cli­ni­cal developments:

- high­ly indi­vi­dua­li­zed immunotherapies
– gene­tic modu­la­ti­on of immu­ne cells
– in-depth under­stan­ding of the skin bar­ri­er and cel­lu­lar stress responses

For the Swiss Der­ma Cli­nic, this means that we con­ti­nue to focus on bio­lo­gi­cal cor­re­la­ti­ons, fol­low the latest immu­no­lo­gy stan­dards and always advi­se our pati­ents based on the latest evidence.

2 CAR‑T cell therapy: precision medicine for autoimmune diseases

Ano­ther mile­stone was the pre­sen­ta­ti­on of new data on CD19 CAR‑T cell the­ra­py, a pro­ce­du­re that ori­gi­na­ted in onco­lo­gy and is now being model-eva­lua­ted for seve­re immu­ne-media­ted dermatosis.

Rese­arch shows:

• Tar­ge­ted eli­mi­na­ti­on of patho­ge­nic immu­ne cell lines
• Long-term remis­si­ons
• New pos­si­bi­li­ties for the­ra­py-refrac­to­ry diseases

While CAR‑T is not yet a der­ma­to­lo­gi­cal stan­dard, we are moni­to­ring the­se deve­lo­p­ments very clo­se­ly. At the Swiss Der­ma Cli­nic, we are alre­a­dy focu­sing on per­so­na­li­zed the­ra­py strategies.

3. mind-skin connection: how psychological stress affects the skin immune system

Ano­ther key topic in Paris was the mind-skin con­nec­tion. New rese­arch data shows the ext­ent to which psy­cho­lo­gi­cal stress alters the cuta­neous immu­ne sys­tem – par­ti­cu­lar­ly in:

• Pso­ria­sis
• ato­pic der­ma­ti­tis (neu­ro­der­ma­ti­tis)
• chro­nic eczema

This has direct the­ra­peu­tic consequences:

• Com­bi­na­ti­on of immu­ne modu­la­ti­on and stress management
• Holi­stic approach for skin and ner­vous system
• Indi­vi­dua­li­zed tre­at­ment accor­ding to stress and inflamm­a­ti­on profile

At the Swiss Der­ma Cli­nic, we are alre­a­dy inte­gra­ting this approach into our tre­at­ment strategy.

4 What does this mean in concrete terms for our patients?

The Swiss Der­ma Cli­nic sees its­elf as a high-end cli­nic for modern der­ma­to­lo­gy, der­ma­to­sur­gery and medi­cal aes­the­tics. Our par­ti­ci­pa­ti­on in inter­na­tio­nal con­gres­ses such as the EADV ensu­res that:

• we imple­ment new sci­en­ti­fic fin­dings at an ear­ly stage
• our dia­gno­stic and the­ra­peu­tic stan­dards remain inter­na­tio­nal­ly leading
• we use sta­te-of-the-art tech­no­lo­gies and evi­dence-based pro­ce­du­res responsibly
• Pati­ents have access to the most effec­ti­ve and safest therapies

For us, inno­va­ti­on is not a mar­ke­ting buz­zword but part of ever­y­day cli­ni­cal practice.

5 Conclusion: Scientific excellence in Paris – implemented in Zurich

Deve­lo­p­ments in der­ma­to­lo­gy are dyna­mic, visio­na­ry and full of new pos­si­bi­li­ties. EADV 2025 has shown once again: The future of our spe­cial­ty is pre­cise, per­so­na­li­zed and interdisciplinary.

For the Swiss Der­ma Cli­nic this means:

We bring the future of der­ma­to­lo­gy direct­ly into our ever­y­day prac­ti­ce in a sci­en­ti­fi­cal­ly sound, huma­ne and always for the bene­fit of our patients.